LONDON, UK / ACCESSWIRE / July 15, 2016 / Active Wall St. announces the list of stocks for today’s coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Drug Manufacturers – Other industry. Companies recently under review include Ionis Pharma, Depomed, Amarin, and United Therapeutics. See our complete notes on Ionis Pharma at:

http://www.activewallst.com/registration-3/?symbol=IONS

Today, AWS is promoting its equity coverage. Get all of our research notes free by signing up to http://www.activewallst.com/register/.

The Drug Manufacturers industry is expected to see positive growth in the next few years despite rising drug prices, health care policies, and fluctuating economic conditions. Let us see how this is affecting some of the big names in the industry. Register with us now for your free membership and more at: http://www.activewallst.com/register/.

Active Wall St. takes a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions.

Ionis Pharmaceuticals Inc. (NASDAQ: IONS)

On Thursday, shares in Carlsbad, California headquartered RNA-targeted drug discovery and development company, Ionis Pharmaceuticals Inc., recorded a trading volume of 2.32 million shares. The stock ended the day at $24.52, which was a slight correction of 0.65%. The Company’s shares have gained 9.71% in the last one month. The stock is trading below its 50-day moving average by 8.22%. Furthermore, shares of Ionis Pharmaceuticals, which focuses on developing drugs for patients with severe and rare diseases, have a Relative Strength Index (RSI) of 47.59.

On July 07, 2016, Ionis Pharmaceuticals announced positive results from two ongoing trials with IONIS-TTRRx. New data from the ongoing open-label extension study of IONIS-TTRRx in patients with familial amyloid polyneuropathy showed that both wild-type and mutant TTR levels were substantially reduced and that the reductions observed were approximately equal in magnitude regardless of the presence or location of the mutation.

Depomed Inc. (NASDAQ: DEPO)

Newark, California headquartered specialty pharmaceutical company, Depomed Inc.’s stock finished yesterday’s session 1.99% higher at $18.92 and with a total volume of 720,680 shares traded. The Company’s shares have advanced 16.65% over the previous three months and 4.36% on an YTD basis. The stock is trading above its 200-day moving average by 7.64%. Furthermore, shares of Depomed, which engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the U.S., have an RSI of 47.36.

On June 24, 2016, Depomed announced that, in response to a second record date request by Starboard Value L.P., it has set a record date of August 19, 2016 to determine shareholders entitled to call a special meeting of shareholders. Depomed today also announced its proposal to hold a special meeting called by its Board on October 28, 2016, that is intended to occur after resolution of the Company’s ongoing NUCYNTA® patent litigation, which is expected no later than September 30, 2016.The complimentary note on DEPO can be accessed at: http://www.activewallst.com/registration-3/?symbol=DEPO.

Amarin Corp. PLC (NASDAQ: AMRN)

At the closing bell on Thursday, shares in Dublin, Ireland-based biopharmaceutical company, Amarin Corp. PLC, climbed 0.45%, ending the day at $2.25. The stock recorded a trading volume of 783,180 shares. The Company’s shares have advanced 6.13% in the last one month, 27.84% in the previous three months and 19.05% since the start of this year. The stock is trading 13.57% above its 50-day moving average and 25.07% above its 200-day moving average. Moreover, shares of Amarin, which focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the U.S., have an RSI of 66.77.

On June 11, 2016 Amarin Corp. announced additional data on Vascepa (icosapent ethyl) at the annual meeting of the American Diabetes Association supporting its efficacy in reducing concentrations of potentially atherogenic lipoproteins in patients with Type 2 diabetes and persistent high triglyceride levels despite statin therapy. Register for free and access the note on AMRN at: http://www.activewallst.com/registration-3/?symbol=AMRN.

United Therapeutics Corp. (NASDAQ: UTHR)

Silver Spring, Maryland headquartered biotechnology company, United Therapeutics Corp.’s stock ended the day 0.89% higher at $110.21 and with a total volume of 430,793 shares traded. The Company’s shares have gained 2.75% in the last month. The stock is trading 0.13% below its 50-day moving average. Additionally, shares of United Therapeutics, which develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening diseases globally, have an RSI of 53.50.

United Therapeutics Corp. is expected to announce second quarter financial results estimates on July 21, 2016. In Its latest earnings announced in April 28, 2016, it posted earnings per share at $4.84 which topped consensus of $3.21. Revenue came in at 369 million versus consensus estimate of 397.42 million. UTHR free note is just a click away at:  http://www.activewallst.com/registration-3/?symbol=UTHR.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 442427

Brave Knight Performance Media Focuses on Providing Effective Advertising Solutions for Apps and Mobile Websites

LOS ANGELES, CA / ACCESSWIRE / July 15, 2016 / An internet marketing executive and successful entrepreneur is pleased to announce the launch of his new company, Brave Knight Performance Media.

As the company spokesperson noted, Brave Knight Performance Media (BKPM) offers top-quality advertising solutions for clients with apps with mobile websites. Thanks to BKPM’s direct user advertisements, the spokesperson said his clients will be able to maximize their LTVs, as well as experience better engagement and higher eCPMs.

“Advertisers can engage diverse personas of audiences through our self-service advertising platform, and for developers, BKPM offers the most advanced monetization solutions for their apps and mobile sites,” said the spokesperson.

Brave Knight Performance Media’s website also features a blog that will provide interesting news about the technology world, as well as what goes on inside the BKPM offices.

“We will also share more about the amazing products my team has developed for you,” the spokesperson said.

The fact the internet marketing veteran and his team would launch a company that offers such innovative help will not surprise the many people who have met and worked with him over the years. The founder who is originally from Buffalo, New York and earned a Bachelor of Science from Rochester Institute of Technology, has earned a well-deserved reputation as an up and coming entrepreneur.

In addition to his work with Brave Knight Performance Media the founder is also a published author, devoted owner of his beloved dog, and enjoys helping people and coaching them to understanding how internet marketing can truly help their business.

Even though the internet entrepreneur only recently launched his new company, it is already getting a lot of attention and positive reviews from customers. For example, as one review on the BKPM website noted, the company’s services were definitely effective.

“BKPM has proven to be one of our most strategically important partners as both companies believe in a future dominated by programmatic and innovative ad units like native and video,” noted the review.

Anybody who would like to learn more about Brave Knight Performance Media is welcome to visit the new website at any time; there, they can read more about the company and the services that are offered.

About Brave Knight Performance Media:

Brave Knight Performance Media is the best advertising solution for peoples’ app and mobile websites. To learn more, please go to: http://www.braveknightperformancemedia.com/.

Contact:

Tommy Johnston
admin@rocketfactor.com
(949) 555-2861

SOURCE: Brave Knight Performance Media

ReleaseID: 442437

In the New Blog, Dorko will Focus on Posting Interesting Articles about a Variety of Healthy Living Topics

LOS ANGELES, CA / ACCESSWIRE / July 15, 2016 / As a fitness and fashion entrepreneur, Irina Dorko is passionate about living a healthy lifestyle. In order to encourage and inspire others to take good care of themselves, Dorko decided to recently launch a new blog.

In addition to in-depth and interesting articles related to a variety of healthy living topics, Dorko will also use her new blog to post inspirational videos.

“I love empowering men and women to live their lives with passion,” noted Dorko, who is also a successful speaker and writer.

Even though Dorko’s new blog has not been live for that long, it is already creating quite a buzz with people who want to learn more about living healthily. For example, Dorko’s article, “iPhone Apps that will Improve Your Health” is quite popular with visitors to the blog.

In the article, Dorko describes some of the many apps that have made adopting a healthy lifestyle as easy as possible. For example, the Fitocracy app allows people to live in a real life video game, and complete a variety of tasks to move up to the next level.

“You can also find workout routines on the app and you can get expert advice,” Dorko said, adding that the app is ideal for people who are already familiar with games like World of Warcraft that require them to improve to the next level.

Another post that is proving to be popular with readers focuses on a topic that many people can relate to: the need to lose weight.

“Like many entrepreneurs, my weight has fluctuated over the years. I’m probably not alone either,” Dorko noted. “Let’s be honest, Losing weight is one of the most common goals that people have with regards to their health.”

In the new blog post, Dorko offers helpful and reassuring tips on how people can successfully lose weight. In addition to setting a daily calorie target, Dorko advises that people focus on realistic and reasonable weight loss goals.

“The healthy approach to weight loss is to drop 0.5 to 2 pounds per week. This should be a good ballpark to estimate just how you will progress with your weight loss journey,” she wrote.

“Forget about going into fad diets because while they promise rapid weight loss, they are far from sustainable and you’ll often gain back the weight and more.”

About Irina Dorko:

Irina Dorko is a fitness and fashion entrepreneur. She also loves living healthily and traveling. Learn more about Ms. Dorko at: https://irinadorkosite.wordpress.com/.

Contact:

Davies Ryan
admin@rocketfactor.com
(949) 555-2861

SOURCE: Irina Dorko

ReleaseID: 442439

VANCOUVER, BC / ACCESSWIRE / July 15, 2016 / Centurion Minerals Ltd. (TSXV: CTN) (“Centurion”, or the “Company”), is pleased to announce that further to its news release of July 7, 2016 regarding a non-brokered private placement for $350,000 priced at $.05/Unit, the Company is increasing the financing to $500,000. All terms of the placement remain the same with each Unit consisting of one common share and one 2 year common share purchase warrant. Each warrant will be exercisable for one common share at $0.10 for the first year and at $0.15 for the second year following the closing. Closing will be subject to TSX Venture Exchange approval.

Proceeds from this financing shall be used to complete a geological model and initial resource estimation work on its Argentinean agricultural gypsum project and for general corporate purposes.

ABOUT CENTURION

Centurion Minerals Ltd. is a Canadian-based company with an international focus on the exploration and development of gold and agri-mineral projects.

On Behalf of the Board,

“David G. Tafel”
President and CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For Further Information Contact:

David Tafel
President and CEO
604-484-2161

This news release may contain forward looking statements concerning future operations of Centurion Minerals Ltd. (the “Company”). All forward looking statements concerning the Company’s future plans and operations, including management’s assessment of the Company’s project expectations or beliefs may be subject to certain assumptions, risks and uncertainties beyond the Company’s control. Investors are cautioned that any such statements are not guarantees of future performance and that actual performance and exploration and financial results may differ materially from any estimates or projections.

SOURCE: Centurion Minerals Ltd.

ReleaseID: 442442

At HantianHealth.com, Customers Can Find Top-Quality Skin Care Products Including
an Advanced Eye Gel that Can Help Repair the Delicate Skin around the Eyes

LOS ANGELES, CA / ACCESSWIRE / July 15, 2016 / The founders of JT Hantian LLC, a company that strives to offer top-quality beauty, fitness and health products, are pleased to announce the launch of their new and user-friendly website.

As a company spokesperson noted, HantianHealth.com only sells products that were made by reputable and trusted manufacturers. This means that customers can rest assured that they are spending their hard-earned money on health and beauty products that have been scientifically tested to be sure they are meeting the minimum standards.

One of the products that is already selling briskly with visitors to the new website is called My Dazzling Serum. The formula is designed to regenerate and revitalize skin, enhance the skin’s natural repair process and reduce overall skin sensitivity. The proprietary blend includes Densiskin and Matrixyl 3000, ingredients that the spokesperson said have been shown to provide effective results.

The Argan Oil by JT Hantian LLC is another product that is getting a lot of attention from customers.

“The pure Moroccan argan oil naturally contains essential fatty acids and antioxidants such as vitamin E, and is trusted for its ability to hydrate both your skin and your hair,” the spokesperson said, adding that people who use argan oil typically report having skin that is better toned, and even a reduction in acne and stretch marks.

My Dazzling Eyes is another product that can be found on the new JT Hantian LLC website. As the spokesperson noted, the formula contains Dupont Glypure and Syn-Coll, two ingredients that help to firm up and restore the delicate skin around the eyes.

People who use My Dazzling Eyes are typically pleased to see a reduction in the appearance of common issues like crow’s feet, dark circles, and bags around the eyes.

Anybody who would like to learn more about JT Hantian LLC is welcome to visit the new and user-friendly website at any time; there, they can browse through the selection of quality health and beauty products. Those who wish to place an order may also do so through the site.

About JT Hantian LLC:

JT Hantian LLC has a unique selection of high quality health products with proven ingredients. For more information, please go to their company website: http://hantianhealth.com/.

Contact:

Glenn Byrd
admin@rocketfactor.com
(949) 555-2861

SOURCE: JT Hantian LLC

ReleaseID: 442440

SILVERDALE, WA / ACCESSWIRE / July 15, 2016 / CGrowth Capital, Inc. (OTC Pink: CGRA) (the “Company”) is pleased to announce that its wholly owned subsidiary, CGrowth Capital Bond, Ltd., has amended its Bond offering in the United Kingdom to £30,000,000 British Pounds Sterling (~$40,000,000 USD). The Company’s decision to increase the Bond followed recent long term interest and commitment by third-parties to fund beyond the initial offering. Details of the amended Bond Issue 1 Series 1 v2.0 will be released shortly under http://CGrowthCapitalBond.com following required administrative procedures.

“We are extremely pleased with the results that we are seeing from the bond offering,” stated Bill Wright, CEO of CGrowth Capital, Inc. “With long term commitments to fund beyond our initial target, we are now able to plan for additional growth well into 2017, evaluate new business and asset opportunities, and take advantage undervalued assets that our currently producing cash flow.”

Mr. Wright continued, “We stated from the beginning that this was not a sprint, but a marathon, and we are continuing to build and push forward. We are committed to maintaining our cap structure, which has not changed in over nine-months. We are working diligently on completing audits and building our team in anticipation of uplisting. We have structured financing to be non-dilutive and put contracts in place to limit any redemption in the short term. And we are extremely excited about the progress being made on our two primary project, which we will be providing updates in the coming days and weeks.”

To date, CGrowth Capital Bond Ltd. has issued bonds totaling nearly £12,000,000 British Pounds Sterling (~$16,000,000 USD) in exchange for cash and other assets. In turn, the Company’s oil and gas project, held under Powder River Resources, has received funding to advance its business in Wyoming.

For more information about CGrowth Capital Bond Ltd. visit: http://CGrowthCapitalBond.com.

About CGrowth Capital, Inc.:

CGrowth Capital, Inc. The Company continues to serve as an alternative asset management company for businesses and assets focused on all aspects of mining, minerals, exploration, and commercial real estate. The processing of metal ore mining, mineral and specialty rock extraction, as well as oil and gas production, are multi-billion dollar market opportunities which is capitalized on through processing, sales, contracting and licensing of assets. CGrowth Capital’s services and solutions are designed to assist land owners with monetizing undervalued assets by bringing commodities such as gold, silver, oil and gas, and dolomite to market. CGrowth Capital will focus on acquiring land assets, while also providing partners and affiliates with management services, capital, contract management and logistical services necessary for the successful execution of operations. Through wholly owned subsidiaries, the Company has begun to strategically leverage real estate assets for maximum value within newly developing industries currently underway in Washington State.

For more information and updates about CGrowth Capital, visit their website or Facebook page:

http://www.CGrowthCapital.com

https://www.facebook.com/CGrowthCapital

Investor Inquiries:
CGrowth Capital, Inc.
360-536-4500

Safe Harbor

Statements about the Company’s future expectations and all other statements in this press release other than historical facts, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. When used in this document, the words “anticipate,” “estimate,” “expect,” “intend,” “plans,” “projects,” and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties. The Company disclaims any obligation to update or revise any forward-looking statements.

SOURCE: CGrowth Capital, Inc.

ReleaseID: 442403